Tonix Pharmaceuticals Holding Corp (TNXP) stock news · rev $13.1M
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
This TNXP news page leads with what Tonix Pharmaceuticals Holding Corp filed — not a scraped headline mill.
No cached 8-K sentence for TNXP yet. We will not pad this page with generic market recap.
Latest reported TNXP revenue for 2025-12-31 was $13.1M. Net income was -$124.0M. Revenue was up 29.8% from 2024-12-31 to 2025-12-31. TNXP currently screens at market cap $194.5M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TNXP stock page; for the tape open the quote page.
TNXP stock news FAQ
What are TNXP's latest revenue and net income?
Latest cached Tonix Pharmaceuticals Holding Corp (TNXP) revenue for Dec 31, 2025 was $13.1M. Net income was -$124.0M. Statements: https://lician.com/financials/tnxp
How did TNXP revenue change from the prior cached period?
Cached Tonix Pharmaceuticals Holding Corp (TNXP) revenue was up 29.8% from $10.1M (Dec 31, 2024) to $13.1M (Dec 31, 2025). Statements: https://lician.com/financials/tnxp
What is TNXP's market cap?
Tonix Pharmaceuticals Holding Corp (TNXP) market cap is $194.5M on the latest cached fundamentals snapshot.
What kind of company is TNXP?
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
Where is TNXP stock news listed?
Cached stock news for Tonix Pharmaceuticals Holding Corp (TNXP) is listed at https://lician.com/news/tnxp. Filings: https://lician.com/sec/tnxp
Not investment advice.